Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001104659-23-028479 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-03 | 2023-03-01 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | M - OptEx | $11.33 | +11.0K | 111.6K | +11% | +$124.3K |
| D | 2023-03-03 | 2023-03-01 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | S - Sale+OE | $36.33 | -11.0K | 100.6K | -10% | -$398.7K |
| D | 2023-03-03 | 2023-03-01 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | M - OptEx | $0.00 | -11.0K | 8,826 | -55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | M | A | 10,974 | $11.33 | 111,588 | D | — | — | (F1) Includes 134 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2022. |
| 2 | Common | Common Stock | 2023-03-01 | S | D | 10,974 | $36.33 | 100,614 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2023-03-01 | M | D | 10,974 | $0.00 | 8,826 | D | $11.33 · — to 2026-03-17 | 10,974 Common Stock | (F3) Shares subject to the option are fully vested and immediately exercisable. |